Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.34% |
| 3 | Industrials | 11.14% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2626
T-REX 2X Long Tesla Daily Target ETF
TSLT
$165M
| $473K | ﹤0.01% |
+27,800
| New | +$604K |
2026 Q1
0 quarters
|
|
|
MAZE
2627
Maze Therapeutics
MAZE
$1.51B
| $472K | ﹤0.01% |
15,800
-11,300
| -42% | -$499K |
2025 Q3
2 quarters
|
|
|
FVR
2628
FrontView REIT
FVR
$406M
| $470K | ﹤0.01% |
30,400
+5,000
| +20% | +$80.6K |
2025 Q2
3 quarters
|
|
2629
Remitly
RELY
$5.11B
| $470K | ﹤0.01% |
30,000
-166,447
| -85% | -$2.46M |
2023 Q4
9 quarters
|
|
2630
United Maritime
USEA
$24.2M
| $470K | ﹤0.01% |
232,535
+157,235
| +209% | +$300K |
2025 Q3
2 quarters
|
|
2631
Actinium Pharmaceuticals
ATNM
$34.6M
| $469K | ﹤0.01% |
471,600
+80,816
| +21% | +$96.1K |
2024 Q2
7 quarters
|
|
2632
RAVE Restaurant Group
RAVE
$32.7M
| $469K | ﹤0.01% |
177,061
+11,205
| +7% | +$33.6K |
2020 Q4
21 quarters
|
|
|
BZUN
2633
Baozun
BZUN
$192M
| $468K | ﹤0.01% |
196,016
-34,228
| -15% | -$89K |
2022 Q1
16 quarters
|
|
2634
Peapack-Gladstone Financial
PGC
$769M
| $468K | ﹤0.01% |
13,294
-17,422
| -57% | -$567K |
2013 Q2
51 quarters
|
|
2635
Ceragon Networks
CRNT
$197M
| $463K | ﹤0.01% |
214,500
+25,800
| +14% | +$58.5K |
2014 Q4
45 quarters
|
|
2636
Oportun Financial
OPRT
$410M
| $461K | ﹤0.01% |
100,079
-32,100
| -24% | -$163K |
2021 Q4
17 quarters
|
|
|
CHCT
2637
Community Healthcare Trust
CHCT
$390M
| $461K | ﹤0.01% |
+29,000
| New | +$489K |
2026 Q1
0 quarters
|
|
2638
HNI Corp
HNI
$3.38B
| $461K | ﹤0.01% |
13,800
-10,146
| -42% | -$449K |
2025 Q4
1 quarter
|
|
|
SUPX
2639
SuperX AI Technology Ltd
SUPX
$303M
| $459K | ﹤0.01% |
57,400
+14,190
| +33% | +$181K |
2025 Q4
1 quarter
|
|
|
KLC
2640
KinderCare Learning Companies
KLC
$222M
| $459K | ﹤0.01% |
208,528
-292,372
| -58% | -$1.1M |
2024 Q4
5 quarters
|
|
2641
Enact Holdings
ACT
$6.32B
| $457K | ﹤0.01% |
11,200
-28,309
| -72% | -$1.16M |
2021 Q4
17 quarters
|
|
2642
Usio Inc
USIO
$79.2M
| $457K | ﹤0.01% |
400,741
-5,400
| -1% | -$7.08K |
2019 Q1
28 quarters
|
|
|
ANL
2643
Adlai Nortye Group ADS
ANL
$1.01B
| $457K | ﹤0.01% |
+66,000
| New | +$441K |
2026 Q1
0 quarters
|
|
|
STEX
2644
Streamex Corp
STEX
$57.2M
| $454K | ﹤0.01% |
+401,604
| New | +$1.02M |
2026 Q1
0 quarters
|
|
2645
Odyssey Marine Exploration
OMEX
$39M
| $452K | ﹤0.01% |
541,721
+53,122
| +11% | +$90.3K |
2025 Q3
2 quarters
|
|
2646
First Trust Smith Unconstrained Bond ETF
UCON
$3.2B
| $451K | ﹤0.01% |
18,200
-10,200
| -36% | -$256K |
2023 Q4
9 quarters
|
|
2647
Purple Innovation
PRPL
$8.15M
| $448K | ﹤0.01% |
27,106
-3,634
| -12% | -$63.6K |
2025 Q3
2 quarters
|
|
|
CBIO
2648
Crescent Biopharma
CBIO
$554M
| $446K | ﹤0.01% |
24,262
-22,438
| -48% | -$258K |
2025 Q3
2 quarters
|
|
2649
ARKO Corp
ARKO
$461M
| $445K | ﹤0.01% |
80,100
+48,400
| +153% | +$270K |
2025 Q3
2 quarters
|
|
2650
First Western Financial
MYFW
$291M
| $445K | ﹤0.01% |
18,100
-22,700
| -56% | -$576K |
2025 Q2
3 quarters
|
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.